BERLIN (Reuters) - German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drug maker.
Reuters: Business News, Reuters: Business
Sun, 04/22/2018 - 2:06pm
BERLIN (Reuters) - German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drug maker.